Home / Stocks / Narayana Hrudayalaya Ltd.
NH

Narayana Hrudayalaya Ltd. Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹1,873.1

Change

-18.2 (-0.96%)

Open

₹1,882.0

Prev. Close

₹1,891.3

Day High

₹1,887.5

Day Low

₹1,848.5

Volume Analysis

Traded

98,925

Delivered

56,051

Delivery %

56.66%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong return on equity (20.5%)

Weaknesses (2)

  • •High debt-to-equity ratio (1.21)
  • •Promoter holding is falling

Opportunities (1)

  • •Strong 3-year revenue growth (20.4%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹1,929.9 ₹1,908.7 ₹1,890.9 ₹1,869.7 ₹1,851.9 ₹1,830.7 ₹1,812.9
Fibonacci ₹1,908.7 ₹1,893.8 ₹1,884.6 ₹1,869.7 ₹1,854.8 ₹1,845.6 ₹1,830.7
Camarilla ₹1,883.83 ₹1,880.25 ₹1,876.68 ₹1,869.7 ₹1,869.53 ₹1,865.95 ₹1,862.38

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-3.17%

1 Week

+1.79%

1 Month

+8.59%

3 Months

+3.16%

6 Months

+0.94%

1 Year

-7.13%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹466.16

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

13.17%

Net margin 8.36% × asset turnover 0.59x × equity multiplier 2.67x

Company Overview

Sector

Healthcare

Market Cap

₹37,889 Cr

P/E (TTM)

41.8

ROE

20.5%

Book Value

₹245.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 19 Nov 2026. Not investment advice.

TopFund Analysis

Narayana Hrudayalaya Ltd. lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 58/100. The strongest factor is Cash Flow (86/100), while Valuation (7/100) is the weakest area to weigh before deciding. Notably: Strong return on equity (20.5%); high debt-to-equity ratio (1.21); promoter holding is falling. FII holding has been falling.

TopFund Score — Fundamentals Quality

58/100 — Average

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

46

Growth

83

Valuation

7

Cash Flow

86

Corporate Governance

61

Momentum

55

Institutional Ownership

35

Business Quality

68

Risk & Volatility

62

Liquidity

82

From Screener.in

  • +Company is expected to give good quarter
  • +Company has a good return on equity (ROE) track record: 3 Years ROE 24.5%
  • −Stock is trading at 7.58 times its book value

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Company to meet Investment Management Corporation of Ontario on November 18 and Wasatch Global Advisors on November 19, 2026.

Narayana Hrudayalaya to meet IC Ontario on Nov 18 and Wasatch Global Advisors on Nov 19, 2026.

Transcript of the Earnings Call for the quarter and half year ended September 30, 2026.

Dr. Devi Prasad Shetty received France’s Knight of National Order of Merit on November 5, 2026.

NCLT sanctioned demerger of 9 Bengaluru and 1 Hosur clinics into Narayana Hrudayalaya; effective date April 1, 2025.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 1,305 1,204 1,246 1,306 1,367 1,335 1,475 1,507 1,644 2,151 2,594 2,684 2,844
Expenses + 997 925 955 1,004 1,058 1,027 1,118 1,171 1,243 1,786 2,086 2,216 2,293
Operating Profit 308 279 291 302 309 307 358 337 401 365 508 468 551
OPM % 24.0% 23.0% 23.0% 23.0% 23.0% 23.0% 24.0% 22.0% 24.0% 17.0% 20.0% 17.0% 19.0%
Other Income + 18 18 26 24 23 18 20 24 24 -29 25 35 52
Interest 23 25 28 34 35 37 41 45 42 65 91 87 97
Depreciation 55 63 65 61 65 70 82 84 87 122 154 156 163
Profit before tax 248 209 225 231 232 219 254 232 296 149 288 260 343
Tax % 9.0% 10.0% 15.0% 13.0% 14.0% 12.0% 22.0% 15.0% 13.0% 15.0% 22.0% 20.0% 12.0%
Net Profit + 227 188 191 202 199 193 197 197 258 127 224 207 301
EPS in Rs 11 9 9 10 10 9 10 10 13 6 11 10 15
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 14 7 2 6 5 11 18 15 20 61 76 78 73

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 1,364 1,614 1,878 2,281 2,861 3,128 2,583 3,701 4,525 4,890 5,483 7,896 10,273
Expenses + 1,236 1,434 1,642 2,064 2,566 2,694 2,394 3,038 3,538 3,722 4,185 6,255 8,380
Operating Profit 128 180 236 217 295 434 189 664 987 1,168 1,298 1,641 1,893
OPM % 9.0% 11.0% 13.0% 10.0% 10.0% 14.0% 7.0% 18.0% 22.0% 24.0% 24.0% 21.0% 18.0%
Other Income + 6 -19 7 18 16 7 21 26 59 73 80 37 83
Interest 45 33 28 55 81 94 82 76 84 112 163 266 340
Depreciation 68 76 80 100 137 186 184 183 210 241 278 448 595
Profit before tax 21 51 135 80 93 161 -56 430 752 888 936 964 1,041
Tax % 71.0% 59.0% 39.0% 36.0% 37.0% 26.0% -75.0% 20.0% 19.0% 11.0% 16.0% 16.0% —
Net Profit + -19 21 83 51 59 119 -14 342 607 790 791 806 859
EPS in Rs -1 1 4 3 3 6 -1 17 30 39 39 39 42
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 35.0% 17.0% 0.0% 6.0% 8.0% 10.0% 12.0% 11.0% —
Sales growth 25 18 16 21 25 9 -17 43 22 8 12 44 72

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 568 672 759 831 877 932 916 1,284 1,927 2,679 3,422 4,333 4,799
Borrowings + 362 258 217 802 813 952 826 723 884 1,627 2,428 5,858 6,075
Other Liabilities + 241 424 468 692 746 813 833 931 1,155 1,123 1,216 2,088 2,289
Total Liabilities 1,371 1,557 1,648 2,529 2,640 2,901 2,779 3,143 4,170 5,633 7,271 12,482 13,367
Fixed Assets + 913 1,054 1,082 1,848 1,838 2,092 1,961 1,980 2,336 2,651 4,266 7,796 8,046
CWIP 20 14 53 35 56 12 20 67 259 514 86 292 328
Investments 52 87 96 9 17 86 120 132 252 844 1,084 573 1,242
Other Assets + 385 402 417 637 729 711 678 964 1,323 1,624 1,835 3,822 3,752
Total Assets 1,371 1,557 1,648 2,529 2,640 2,901 2,779 3,143 4,170 5,633 7,271 12,482 13,367
Equity Capital 200 204 204 204 204 204 204 204 204 204 204 204 204

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 77 174 219 182 279 443 304 485 1,085 1,067 986 1,621
Cash from Investing Activity + -223 -150 -146 -520 -162 -189 -113 -267 -1,176 -1,458 -1,325 -3,648
Cash from Financing Activity + 140 18 -45 315 -27 -247 -194 -159 88 488 544 2,340
Net Cash Flow -6 42 28 -22 89 7 -2 59 -4 97 205 313
Free Cash Flow -15 86 85 -20 129 329 235 235 563 99 -93 753
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 78 116 108 100 113 117 133 83 119 99 86 108

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 63.85% → 63.27%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Others 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62% 0.62%
Public 13.78% 15.12% 17.29% 17.94% 17.39% 17.34% 16.98% 17.29% 17.09% 16.98% 17.65% 16.42%
Promoters 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.85% 63.27% 63.27% 63.27% 63.27%
Government 0.0% 0.01% 0.01% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FII 11.51% 10.91% 10.01% 9.69% 9.45% 9.66% 10.46% 10.49% 11.1% 9.98% 9.4% 9.01%
DII 10.23% 9.51% 8.22% 7.9% 8.68% 8.52% 8.09% 7.76% 7.91% 9.14% 9.05% 10.68%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Narayana Hrudayalaya Ltd. (this stock) 37,889 41.8 7.57 20.5%
Sai Life Sciences Limited 38,018 99.5 14.08 15.4%
Global Health Limited 38,864 60.0 8.97 15.2%
Ajanta Pharma Limited 41,393 32.8 8.51 27.1%
Dr. Lal Path Labs Ltd. 33,582 55.5 12.2 22.3%
Wockhardt Limited 32,944 82.4 6.39 6.11%
Piramal Pharma Limited 32,557 — 4.0 -3.83%

Which Mutual Funds Hold Narayana Hrudayalaya Ltd.?

Frequently Asked Questions about Narayana Hrudayalaya Ltd.

Community Sentiment

What are other investors saying about Narayana Hrudayalaya Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.